Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 163

    CDSCO calls for crackdown on Buclizine sales; Mankind Pharma taken to court: Report

    CDSCO calls for crackdown on Buclizine sales; Mankind Pharma taken to court: Report

    Meghna A Singhania3 April 2019 11:45 AM IST
    Those found manufacturing, selling or distributing buclizine on or after December 13 without adhering to the orders given by CDSCO, will be liable for...
    Dr Reddys arm sells US rights for Sernivo, Promises, Trianex to Encore Dermatology

    Dr Reddy's arm sells US rights for Sernivo, Promises, Trianex to Encore Dermatology

    Farhat Nasim3 April 2019 9:30 AM IST
    Dr Reddy's co-chairman and CEO G V Prasad said the announcement is in line with its renewed strategy to enable us to achieve self-sustainability and...
    USFDA issues warning letter to Rajasthan based homeopathic firm and 3 others

    USFDA issues warning letter to Rajasthan based homeopathic firm and 3 others

    Farhat Nasim3 April 2019 9:25 AM IST
    New Delhi: The U.S. Food and Drug Administration (USFDA) recently posted warning letters to four companies producing homoeopathic drug products for...
    Pfizer participates in SpringWorks Therapeutics USD125 million Series B financing

    Pfizer participates in SpringWorks Therapeutics' USD125 million Series B financing

    Garima3 April 2019 9:15 AM IST
    All of the SpringWorks Therapeutics' existing investors, OrbiMed, Bain Capital, Pfizer, via Pfizer Ventures, and LifeArc have also participated in the...
    Novartis to face lawsuit over doctor kickbacks

    Novartis to face lawsuit over doctor kickbacks

    Garima3 April 2019 9:10 AM IST
    The case began in 2011 as a whistleblower lawsuit filed by Oswald Bilotta, a former Novartis sales representative. Such lawsuits, brought under the...
    China to regulate all fentanyl drugs as controlled substance

    China to regulate all fentanyl drugs as controlled substance

    Medical Dialogues Bureau3 April 2019 9:00 AM IST
    China already controls more than two dozen variants of fentanyl, plus two precursors. Data from the U.S. Drug Enforcement Administration has shown...
    Lupin gets EIR from USFDA for Pithampur unit

    Lupin gets EIR from USFDA for Pithampur unit

    Farhat Nasim2 April 2019 12:35 PM IST
    Lupin said its Pithampur Unit-3 facility is involved in the manufacture of metered dose inhalers (MDis), dry powder inhalers (DPis) and topical...
    Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

    Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

    Meghna A Singhania2 April 2019 12:34 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling...
    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Farhat Nasim2 April 2019 11:50 AM IST
    The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
    Price Fixation: NPPA revises ceiling price of 8 IV fluids including Glucose; Details

    Price Fixation: NPPA revises ceiling price of 8 IV fluids including Glucose; Details

    Meghna A Singhania2 April 2019 11:45 AM IST
    NEW DELHI: Through a recent official release, National Pharmaceutical Pricing Authority (NPPA) has informed about the revision in the ceiling price of...
    Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole

    Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole

    Garima2 April 2019 9:45 AM IST
    The agreement has been signed between the company's wholly-owned subsidiary in the US, Cipla Technologies LLC with Pulmatrix Inc for investment in...
    Novartis to pay $310 million for assets from inflammation specialist IFM

    Novartis to pay $310 million for assets from inflammation specialist IFM

    Garima2 April 2019 9:00 AM IST
    IFM, whose research head Martin Seidel spent more than a decade at Novartis before assuming R&D duties at IFM in 2017, focuses on immune system...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    Pharma Export do not need NOC: CDSCO

    Pharma Export do not need NOC: CDSCO

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok